Purchases and Sales Made in Q1 2025 in Eledon Pharmaceuticals, Inc. (ELDN)
This table provides information about the institutional ownership of Eledon Pharmaceuticals, Inc. (ELDN) during Q1 2025. The information is specifically focused on institutions that hold shares of Eledon Pharmaceuticals, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 15, 2025
Q1 2025
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-95.9K- 50.49% |
$321K - $463K
|
94K
$253K
|
|
|
May 15, 2025
Q1 2025
|
Ikarian Capital, LLC
Dallas, TX |
SELL
|
- |
-101K- 9.0% |
$340K - $490K
|
1.03M
$2.76M
|
|
|
May 15, 2025
Q1 2025
|
Blue Owl Capital Holdings LP
New York, NY |
SELL
|
- |
-140K- 7.14% |
$469K - $676K
|
1.82M
$4.9M
|
|
|
May 15, 2025
Q1 2025
|
Exome Asset Management LLC
New York, NY |
SELL
|
- |
-142K- 55.48% |
$476K - $687K
|
114K
$307K
|
|
|
May 15, 2025
Q1 2025
|
Schonfeld Strategic Advisors LLC
New York, NY |
SELL
|
- |
-197K- 12.99% |
$660K - $951K
|
1.32M
$3.55M
|
|
|
May 15, 2025
Q1 2025
|
Sphera Funds Management Ltd.
Tel Aviv, L3 |
SELL
|
- |
-245K- 9.58% |
$819K - $1.18M
|
2.31M
$6.21M
|
|
|
May 13, 2025
Q1 2025
|
Ubs Group Ag
|
SELL
|
- |
-295K- 92.71% |
$989K - $1.43M
|
23.2K
$62.5K
|